The SLU-PP-332 research vial contains 2mg of high-purity synthetic pan-agonist targeting estrogen-related receptors (ERRα, ERRβ, and ERRγ) for cellular energy expenditure and oxidative metabolism research. Formulated exclusively for in vitro and preclinical laboratory applications, each lot undergoes third-party HPLC and mass spectrometry verification to guarantee maximum analytical precision.
The SLU-PP-332 research vial contains 2mg of high-purity synthetic pan-agonist targeting estrogen-related receptors (ERRα, ERRβ, and ERRγ) for cellular energy expenditure and oxidative metabolism research. Formulated exclusively for in vitro and preclinical laboratory applications, each lot undergoes third-party HPLC and mass spectrometry verification to guarantee maximum analytical precision.
The SLU-PP-332 research vial represents a specialized small-molecule tool compound designed to activate nuclear receptor signaling pathways involved in cellular energy expenditure. Classified as a synthetic pan-agonist of estrogen-related receptors (ERRs), SLU-PP-332 allows investigators to analyze the transcriptomic networks that control mitochondrial function, fatty acid oxidation, and metabolic rate without directly engaging classical estrogen receptors (ERα or ERβ).
In preclinical laboratory settings, researchers utilize SLU-PP-332 to probe muscle gene expression programs typically stimulated by exercise or caloric restriction. By selectively activating ERR signaling, this research compound provides an isolated molecular model to evaluate how mitochondrial density and oxidative phosphorylation capacity adapt to targeted transcriptional cues. All units supplied by PX1 Research are intended strictly for laboratory evaluation, cell culture experiments, and controlled animal research models.
Estrogen-related receptors belong to the orphan nuclear receptor superfamily, comprising three distinct isoforms: ERRα, ERRβ, and ERRγ. Unlike classical estrogen receptors, ERRs do not bind endogenous estradiol with high affinity. Instead, they act as constitutive transcriptional regulators of metabolic genes, frequently interacting with the coactivator PGC-1α. The SLU-PP-332 research vial provides researchers with a non-steroidal agonist capable of potently activating all three ERR isoforms in cell culture and tissue models.
Preclinical data indicate that binding of SLU-PP-332 to the ligand-binding domain of ERR induces structural changes that promote coactivator recruitment. This cascade upregulates downstream target genes encoding enzymes essential for mitochondrial electron transport, pyruvate oxidation, and beta-oxidation of fatty acids. Laboratory assays focused on transcription dynamics utilize SLU-PP-332 to map specific promoter interactions across our comprehensive catalog of research peptides and metabolic signaling modulators.
Cellular energy expenditure is tightly regulated by mitochondrial volume and the functional efficiency of the respiratory chain. In vitro models utilizing skeletal muscle cell lines (such as C2C12 myotubes) or primary adipocyte cultures demonstrate that exposure to SLU-PP-332 increases basal oxygen consumption rates (OCR) and maximal respiratory capacity without compromising mitochondrial membrane integrity.
Researchers conducting extracellular flux analysis utilize the SLU-PP-332 research vial to quantify changes in proton leak, ATP production-coupled respiration, and spare respiratory capacity. These studies help illuminate how orphan nuclear receptors coordinate metabolic switching from glycolytic pathways to lipid oxidation, offering crucial baseline data for broader studies published in our research library hub.
Within metabolic and strength-related preclinical research, several distinct chemical classes are evaluated for their potential to alter energy expenditure and substrate utilization. While SLU-PP-332 functions directly as a pan-ERR agonist, other investigational targets operate through distinct enzyme inhibition or mitochondrial peptide pathways. Comparative assays often benchmark SLU-PP-332 against compounds like 5-Amino-1MQ, a small-molecule NNMT inhibitor, or MOTS-c, a mitochondrial-derived peptide involved in metabolic homeostasis.
In contrast to enzyme inhibitors that raise intracellular NAD+ levels or peptide analogs that modulate nuclear translocation of transcription factors during cellular stress, the SLU-PP-332 research vial directly targets nuclear receptor transcriptional complexes. Researchers investigating muscle endurance, mitochondrial biogenesis, and lipid turnover often run parallel assays incorporating mitochondrial research compounds alongside ERR agonists to map overlapping versus distinct metabolic signatures.
Reproducibility in metabolic research depends heavily on the chemical purity and analytical consistency of test reagents. Each 2mg SLU-PP-332 research vial produced for PX1 Research is subjected to rigorous analytical testing within an ISO 17025 accredited laboratory prior to release. Every batch undergoes High-Performance Liquid Chromatography (HPLC) to confirm high chemical purity, combined with Mass Spectrometry (MS) to verify precise molecular mass and structure.
Furthermore, because bacterial impurities can artifactually stimulate metabolic pathways or alter mitochondrial respiration assays, PX1 Research subjects every production lot to chromogenic endotoxin testing. Researchers can access lot-specific Certificates of Analysis (COAs) directly through our portal, ensuring full traceability and transparency for institutional compliance.
To maintain the highest standard among US research suppliers, PX1 Research adheres to strict operational and analytical protocols. Institutional procurement teams evaluating candidate vendors can compare our baseline quality controls:
- **Chemical Purity Verification:** Reverse-Phase HPLC (RP-HPLC) analysis confirming baseline purity exceeding industry standards. - **Structural Identity Confirmation:** Mass Spectrometry (ESI-MS or MALDI-TOF) matching exact monoisotopic weight. - **Endotoxin Control:** Kinetic chromogenic LAL testing ensuring endotoxin levels remain below stringent thresholds suitable for cell culture. - **US Manufacturing & Traceability:** Synthesized and packaged in GMP-compliant facilities within the United States with full lot-number tracking. - **Rapid Cold-Chain Logistics:** Standardized same-day dispatch (Monday–Friday) operating from distribution centers in California and Arizona.
SLU-PP-332 is a hydrophobic synthetic organic molecule supplied as a sterile, lyophilized cake in a sealed glass vial. Unlike hydrophilic peptides that dissolve readily in plain sterile water, SLU-PP-332 requires appropriate organic co-solvents for complete dissolution prior to introduction into aqueous buffer systems.
For stock solution preparation in cell culture or cell-free assays, dimethyl sulfoxide (DMSO) or ethanol is typically recommended as the primary solvent. Investigators should first reconstitute the contents of the SLU-PP-332 research vial in high-purity DMSO to achieve the desired stock concentration (e.g., 10 mM to 50 mM). Once fully dissolved, stock aliquots can be diluted into culture media or physiological buffers, ensuring the final DMSO concentration does not exceed acceptable thresholds for the specific cell line being tested (typically <0.1% v/v).
Proper handling and storage are necessary to maintain the chemical integrity of the SLU-PP-332 research vial over extended experimental timelines. Lyophilized vials should be stored at -20°C upon receipt, protected from light and moisture. Under these desiccated, sub-zero conditions, the compound remains stable for extended periods without significant degradation.
Once reconstituted in solvent, stock solutions should be divided into single-use micro-aliquots to avoid repeated freeze-thaw cycles, which can induce compound precipitation or chemical alteration. Stock solutions stored in DMSO at -80°C maintain high stability. Researchers requiring large-scale stock preparations for institutional facilities can explore bulk supply terms through our wholesale account portal.
What is the primary utility of a slu-pp-332 research vial?
The slu-pp-332 research vial is utilized in laboratory settings as a synthetic pan-agonist of estrogen-related receptors (ERRα, ERRβ, ERRγ) to study cellular energy expenditure, mitochondrial biogenesis, and oxidative gene expression.
What purity level is guaranteed for the SLU-PP-332 research vial?
Every SLU-PP-332 research vial supplied by PX1 Research undergoes RP-HPLC and mass spectrometry testing to verify structural identity and high purity (typically ≥98%), accompanied by a lot-specific Certificate of Analysis.
How should a 2mg SLU-PP-332 vial be reconstituted for cell culture assays?
Because SLU-PP-332 is a hydrophobic small molecule, it should be reconstituted initially in an organic solvent like DMSO to create a concentrated stock solution before further dilution into aqueous assay buffers or culture media.
Does SLU-PP-332 bind to classical estrogen receptors ERα or ERβ?
No. Preclinical characterization indicates that SLU-PP-332 is a selective pan-agonist for orphan estrogen-related receptors (ERRs) and does not display significant agonist activity at classical ERα or ERβ receptors.
How is the endotoxin level in SLU-PP-332 verified?
PX1 Research conducts kinetic chromogenic LAL endotoxin assays on every production lot to ensure bacterial endotoxin levels meet strict laboratory standards prior to shipping.
What is the recommended storage temperature for lyophilized SLU-PP-332?
Lyophilized SLU-PP-332 vials should be stored at -20°C in a dry, dark environment. Reconstituted solvent stocks should be stored at -80°C in single-use aliquots.
Where does PX1 Research manufacture and ship SLU-PP-332 research vials?
SLU-PP-332 research vials are manufactured in US-based GMP-compliant facilities and shipped same-day (Monday through Friday) from our fulfillment centers located in California and Arizona.
Is SLU-PP-332 suitable for human consumption or clinical administration?
No. SLU-PP-332 is strictly designated as a research chemical for in vitro laboratory research and preclinical animal studies. It is not for human or veterinary use.
How does SLU-PP-332 differ from other metabolic research peptides like MOTS-c?
SLU-PP-332 is a synthetic small-molecule pan-ERR nuclear receptor agonist, whereas MOTS-c is a mitochondrial-derived peptide that acts on distinct metabolic nuclear translocation pathways.
Can institutional laboratories purchase SLU-PP-332 in bulk quantity?
Yes. Institutional facilities and academic labs requiring larger quantities for ongoing research projects can apply for bulk tier terms via our wholesale portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.